QA: MIRA Pharmaceuticals INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001904286_2025_MIRA_Pharmaceuticals_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001904286, MIRA Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 2,887,660
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 35,439
4 LiabilitiesCurrent 723,349
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,712,753
9 ResearchAndDevelopmentExpense 3,305,575
10 remainder_Expenses -165,669
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,923,099
1 Liabilities 723,349
2 Expenses 7,852,659
3 Revenues 0
4 StockholdersEquity 2,199,750
5 NetIncome -7,852,659
6 ComprehensiveNetIncome -7,852,659
7 BaseVar 5,749,554
8 EconomicCapitalRatiobeforeLimitedLiability -1.68
9 EconomicCapitalRatio 1.13

Edgar->Model Mapping

Feature Distribution

Change over Time